UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 69

Sortiert nach

Memory CD4+ T cells do not induce graft-versus-host disease

The Journal of clinical investigation, 2003-07, Vol.112 (1), p.101-108

2003

Volltextzugriff (PDF)

Autocrine/paracrine TGFβ1 is required for the development of epidermal Langerhans cells

The Journal of experimental medicine, 2007-10, Vol.204 (11), p.2545-2552

2007

Volltextzugriff (PDF)

Memory T Cells from Minor Histocompatibility Antigen-Vaccinated Donors Improve Engraftment with Low Intensity Conditioning

Blood, 2017-12, Vol.130, p.4436-4436

2017

Volltextzugriff (PDF)

A Phase 1/1b Multicenter Ascending Dose Study to Evaluate the Safety of HA-1 Minor Histocompatibility Antigen-Reactive TCR-Modified T Cells (BSB-1001) in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant (alloSCT) for MRD+ AML or ALL or Poor/Very Poor Risk MDS

Blood, 2022-11, Vol.140 (Supplement 1), p.7482-7483

2022

Volltextzugriff (PDF)

Pilot Trial of IFN-γ and Donor Lymphocyte Infusion to Treat Relapsed AML and MDS after Allogeneic Hematopoietic Stem Cell Transplantation

Blood, 2022-11, Vol.140 (Supplement 1), p.7678-7679

2022

Volltextzugriff (PDF)

Tissue-Derived IL-33 Is a Critical Local Signal That Targets Th1 Cells in the Small Intestine to Sustain Graft Versus Host Disease in the Absence of IL-12

Blood, 2020-11, Vol.136 (Supplement 1), p.1-2

2020

Volltextzugriff (PDF)

Chemokine receptors are required for effector T cell trafficking to GVHD tissues but not to bone marrow

Blood advances, 2024-08

2024

Volltextzugriff (PDF)

Disruption of IL-33-mediated costimulation to CD4 +T cells leads to peripheral Treg generation and resolution of T cell-mediated pathology

The Journal of immunology (1950), 2023-05, Vol.210 (1_Supplement), p.76-76.12

2023

Volltextzugriff (PDF)

CD8+ Effector T Cell Migration into the Bone Marrow of Transplanted Mice: Influence of Gvhd, Leukemia Cells and Variable Dependence on Chemokine Receptors

Blood, 2018-11, Vol.132 (Supplement 1), p.2043-2043

2018

Volltextzugriff (PDF)

Spontaneous Remission of Secondary Acute Lymphoblastic Leukemia Associated with Lenalidomide Therapy for Multiple Myeloma

Blood, 2019-11, Vol.134 (Supplement_1), p.5200-5200

2019

Volltextzugriff (PDF)

Identifying the Clonal Origins of Gvhd-Causing T Cells

Blood, 2016-12, Vol.128 (22), p.497-497

2016

Volltextzugriff (PDF)

Identifying Tissue-Resident Memory T Cells in Graft-Versus-Host Disease

Blood, 2016-12, Vol.128 (22), p.4544-4544

2016

Volltextzugriff (PDF)

TCF-1+ T Cells Sustain Alloimmune Responses in Graft-Vs-Host Disease

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S282-S283

2022

Volltextzugriff (PDF)

365 - TCF-1+ T Cells Sustain Alloimmune Responses in Graft-Vs-Host Disease

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S282-S283

2022

Volltextzugriff (PDF)

Blast Crisis CML Cells Require IFN-γ Conditioning For Effective GVL Whereas Chronic Phase CML Cells Do Not: An Explanation For Chronic Phase CML GVL-Sensitivity

Blood, 2013-11, Vol.122 (21), p.2013-2013

2013

Volltextzugriff (PDF)

Mechanisms of GVL-Resistance: T Cell Exhaustion and a Failure of Antigen Cross-Presentation

Blood, 2017-12, Vol.130, p.4461-4461

2017

Volltextzugriff (PDF)

GVHD Is Sustained By T Cell Maintenance within Target Tissues: Insights from Clonal Tracking and Parabiosis

Blood, 2018-11, Vol.132 (Supplement 1), p.809-809

2018

Volltextzugriff (PDF)

PD-L1 Prevents the Development of Autoimmune Heart Disease in Graft-vs-Host Disease

The Journal of immunology (1950), 2017-12, Vol.200 (2), p.834-846

2017

Volltextzugriff (PDF)

T Cells Motility in the Colonic Gvhd Is Influenced By Both Cognate Interaction and Microenvironment

Blood, 2016-12, Vol.128 (22), p.3346-3346

2016

Volltextzugriff (PDF)

NaïVe T Cell Depletion of PBSC Grafts Results in Very Low Rates of Chronic Gvhd and High Survival

Blood, 2016-12, Vol.128 (22), p.668-668

2016

Volltextzugriff (PDF)

A Pipeline for Optimizing miHA Specific TCR Therapy for Leukemia

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S218-S219

2022

Volltextzugriff (PDF)

274 - A Pipeline for Optimizing miHA Specific TCR Therapy for Leukemia

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S218-S219

2022

Volltextzugriff (PDF)

287 - A Phase 1/1b Multicenter Ascending Dose Study to Evaluate the Safety of HA-1 Minor Histocompatibility Antigen-Reactive TCR-Modified T Cells (BSB-1001) in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant (alloSCT) for MRD+ AML or ALL or High/Very High Risk MDS

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S221-S221

2023

Volltextzugriff (PDF)

A Phase 1/1b Multicenter Ascending Dose Study to Evaluate the Safety of HA-1 Minor Histocompatibility Antigen-Reactive TCR-Modified T Cells (BSB-1001) in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant (alloSCT) for MRD+ AML or ALL or High/Very High Risk MDS

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S221

2023

Volltextzugriff (PDF)

Differential requirements for myeloid leukemia IFN-[gamma] conditioning determine graft-versus-leukemia resistance and sensitivity

The Journal of clinical investigation, 2017-07, Vol.127 (7), p.2765

2017

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(66)
Buchkapitel
(3)

Sprache

Englisch
(69)
Japanisch
(1)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Memory CD4+ T cells do not induce graft-versus-host disease

Autocrine/paracrine TGFβ1 is required for the development of epidermal Langerhans cells

Memory T Cells from Minor Histocompatibility Antigen-Vaccinated Donors Improve Engraftment with Low Intensity Conditioning

A Phase 1/1b Multicenter Ascending Dose Study to Evaluate the Safety of HA-1 Minor Histocompatibility Antigen-Reactive TCR-Modified T Cells (BSB-1001) in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant (alloSCT) for MRD+ AML or ALL or Poor/Very Poor Risk MDS

Pilot Trial of IFN-γ and Donor Lymphocyte Infusion to Treat Relapsed AML and MDS after Allogeneic Hematopoietic Stem Cell Transplantation

Tissue-Derived IL-33 Is a Critical Local Signal That Targets Th1 Cells in the Small Intestine to Sustain Graft Versus Host Disease in the Absence of IL-12

Chemokine receptors are required for effector T cell trafficking to GVHD tissues but not to bone marrow

Disruption of IL-33-mediated costimulation to CD4 +T cells leads to peripheral Treg generation and resolution of T cell-mediated pathology

CD8+ Effector T Cell Migration into the Bone Marrow of Transplanted Mice: Influence of Gvhd, Leukemia Cells and Variable Dependence on Chemokine Receptors

Spontaneous Remission of Secondary Acute Lymphoblastic Leukemia Associated with Lenalidomide Therapy for Multiple Myeloma

Identifying the Clonal Origins of Gvhd-Causing T Cells

Identifying Tissue-Resident Memory T Cells in Graft-Versus-Host Disease

TCF-1+ T Cells Sustain Alloimmune Responses in Graft-Vs-Host Disease

365 - TCF-1+ T Cells Sustain Alloimmune Responses in Graft-Vs-Host Disease

Blast Crisis CML Cells Require IFN-γ Conditioning For Effective GVL Whereas Chronic Phase CML Cells Do Not: An Explanation For Chronic Phase CML GVL-Sensitivity

Mechanisms of GVL-Resistance: T Cell Exhaustion and a Failure of Antigen Cross-Presentation

GVHD Is Sustained By T Cell Maintenance within Target Tissues: Insights from Clonal Tracking and Parabiosis

PD-L1 Prevents the Development of Autoimmune Heart Disease in Graft-vs-Host Disease

T Cells Motility in the Colonic Gvhd Is Influenced By Both Cognate Interaction and Microenvironment

NaïVe T Cell Depletion of PBSC Grafts Results in Very Low Rates of Chronic Gvhd and High Survival

A Pipeline for Optimizing miHA Specific TCR Therapy for Leukemia

274 - A Pipeline for Optimizing miHA Specific TCR Therapy for Leukemia

287 - A Phase 1/1b Multicenter Ascending Dose Study to Evaluate the Safety of HA-1 Minor Histocompatibility Antigen-Reactive TCR-Modified T Cells (BSB-1001) in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant (alloSCT) for MRD+ AML or ALL or High/Very High Risk MDS

A Phase 1/1b Multicenter Ascending Dose Study to Evaluate the Safety of HA-1 Minor Histocompatibility Antigen-Reactive TCR-Modified T Cells (BSB-1001) in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant (alloSCT) for MRD+ AML or ALL or High/Very High Risk MDS

Differential requirements for myeloid leukemia IFN-[gamma] conditioning determine graft-versus-leukemia resistance and sensitivity

Aktive Filter

Suchergebnisse filtern